Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.
Fatteh M, Wehr J, Karaindrou K, Xian RR, Gocke C, Lin MT, Petry D, Visvanathan K, Couzi R, Santa Maria C, Stearns V, Tao JJ, Anagnostou V, Canzoniero JV; and the Johns Hopkins Molecular Tumor Board; Johns Hopkins Molecular Tumor Board. Fatteh M, et al. Among authors: anagnostou v. JCO Precis Oncol. 2024 Oct;8:e2400254. doi: 10.1200/PO.24.00254. Epub 2024 Oct 11. JCO Precis Oncol. 2024. PMID: 39393037
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Skoulidis F, Araujo HA, Do MT, Qian Y, Sun X, Cobo AG, Le JT, Montesion M, Palmer R, Jahchan N, Juan JM, Min C, Yu Y, Pan X, Arbour KC, Vokes N, Schmidt ST, Molkentine D, Owen DH, Memmott R, Patil PD, Marmarelis ME, Awad MM, Murray JC, Hellyer JA, Gainor JF, Dimou A, Bestvina CM, Shu CA, Riess JW, Blakely CM, Pecot CV, Mezquita L, Tabbó F, Scheffler M, Digumarthy S, Mooradian MJ, Sacher AG, Lau SCM, Saltos AN, Rotow J, Johnson RP, Liu C, Stewart T, Goldberg SB, Killam J, Walther Z, Schalper K, Davies KD, Woodcock MG, Anagnostou V, Marrone KA, Forde PM, Ricciuti B, Venkatraman D, Van Allen EM, Cummings AL, Goldman JW, Shaish H, Kier M, Katz S, Aggarwal C, Ni Y, Azok JT, Segal J, Ritterhouse L, Neal JW, Lacroix L, Elamin YY, Negrao MV, Le X, Lam VK, Lewis WE, Kemp HN, Carter B, Roth JA, Swisher S, Lee R, Zhou T, Poteete A, Kong Y, Takehara T, Paula AG, Parra Cuentas ER, Behrens C, Wistuba II, Zhang J, Blumenschein GR, Gay C, Byers LA, Gibbons DL, Tsao A, Lee JJ, Bivona TG, Camidge DR, Gray JE, Lieghl N, Levy B, Brahmer JR, Garassino MC, Gandara DR, Garon EB, Rizvi NA, Scagliotti GV, Wolf J, Planchard D, Besse B, Herbst RS, Wakelee HA, Pennell NA, Shaw AT, Jänne PA, Carbone DP… See abstract for full author list ➔ Skoulidis F, et al. Among authors: anagnostou v. Nature. 2024 Oct 9. doi: 10.1038/s41586-024-07943-7. Online ahead of print. Nature. 2024. PMID: 39385035
A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.
Botsis T, Spiker J, Kreimeyer K, Fatteh M, Wehr J, Najjar M, Tao J, Xian R, Imamovic NL, Pindzola A, Dobs A, Canzoniero J, Anagnostou V. Botsis T, et al. Among authors: anagnostou v. Stud Health Technol Inform. 2024 Aug 22;316:1854-1855. doi: 10.3233/SHTI240792. Stud Health Technol Inform. 2024. PMID: 39176852
Exploiting temporal aspects of cancer immunotherapy.
Zemek RM, Anagnostou V, Pires da Silva I, Long GV, Lesterhuis WJ. Zemek RM, et al. Among authors: anagnostou v. Nat Rev Cancer. 2024 Jul;24(7):480-497. doi: 10.1038/s41568-024-00699-2. Epub 2024 Jun 17. Nat Rev Cancer. 2024. PMID: 38886574 Review.
Type I Diabetes Mellitus Suppresses Experimental Skin Carcinogenesis.
Giakoumaki M, Lambrou GI, Vlachodimitropoulos D, Tagka A, Vitsos A, Kyriazi M, Dimakopoulou A, Anagnostou V, Karasmani M, Deli H, Grigoropoulos A, Karalis E, Rallis MC, Black HS. Giakoumaki M, et al. Among authors: anagnostou v. Cancers (Basel). 2024 Apr 15;16(8):1507. doi: 10.3390/cancers16081507. Cancers (Basel). 2024. PMID: 38672589 Free PMC article.
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.
Kelly RJ, Landon BV, Zaidi AH, Singh D, Canzoniero JV, Balan A, Hales RK, Voong KR, Battafarano RJ, Jobe BA, Yang SC, Broderick S, Ha J, Marrone KA, Pereira G, Rao N, Borole A, Karaindrou K, Belcaid Z, White JR, Ke S, Amjad AI, Weksler B, Shin EJ, Thompson E, Smith KN, Pardoll DM, Hu C, Feliciano JL, Anagnostou V, Lam VK. Kelly RJ, et al. Among authors: anagnostou v. Nat Med. 2024 Apr;30(4):1023-1034. doi: 10.1038/s41591-024-02877-z. Epub 2024 Mar 19. Nat Med. 2024. PMID: 38504015 Free PMC article. Clinical Trial.
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.
Nakazawa M, Harada G, Ghanem P, Bubie A, Kiedrowski LA, Murray JC, Marrone KA, Scott SC, Houseknecht S, Falcon CJ, Evans P, Feliciano J, Hann CL, Ettinger DS, Smith KN, Anagnostou V, Forde PM, Brahmer JR, Levy B, Drilon A, Lam VK. Nakazawa M, et al. Among authors: anagnostou v. Cancer Res Commun. 2024 Mar 14;4(3):786-795. doi: 10.1158/2767-9764.CRC-24-0065. Cancer Res Commun. 2024. PMID: 38407352 Free PMC article.
Exploiting the beneficial effects of Salvia officinalis L. extracts in human health and assessing their activity as potent functional regulators of food microbiota.
Kompoura V, Karapantzou I, Mitropoulou G, Parisis NA, Gkalpinos VK, Anagnostou VA, Tsiailanis AD, Vasdekis EP, Koutsaliaris IK, Tsouka AN, Karapetsi L, Madesis P, Letsiou S, Florou D, Koukkou AI, Barbouti A, Tselepis AD, Kourkoutas Y, Tzakos AG. Kompoura V, et al. Among authors: anagnostou va. Food Chem. 2024 May 30;441:138175. doi: 10.1016/j.foodchem.2023.138175. Epub 2023 Dec 9. Food Chem. 2024. PMID: 38194793
120 results